A prospective observation study of Japanese patients with locally advanced squamous cell carcinoma of the head and neck treated by radiotherapy with cetuximab （JROSG12-2）: interim appraisal of the safety and treatment compliance-Reference-Cited by-同舟云学术

A prospective observation study of Japanese patients with locally advanced squamous cell carcinoma of the head and neck treated by radiotherapy with cetuximab （JROSG12-2）: interim appraisal of the safety and treatment compliance

Published:2019 Issue:3 Volume:45 Page:330-336
ISSN:1349-5747
Container-title:Toukeibu Gan
language:en
Short-container-title:Toukeibu Gan

Author:

Ota Yosuke¹,Kodaira Takeshi²,Fujii Hirofumi³,Shimokawa Mototsugu⁴,Nakashima Torahiko⁵,Monden Nobuya⁶,Yokota Tomoya⁷,Homma Akihiro⁸,Ueda Shinya⁹,Akimoto Tetsuo¹⁰

Affiliation:

1. Department of Radiation Oncology, Hyogo Cancer Center

2. Department of Therapeutic Radiation Oncology, Aichi Cancer Center Hospital

3. Department of Clinical Oncology, Jichi Medical University

4. Clinical Research Institute, National Hospital Organization Kyushu Cancer Center

5. Department of Otorhinolaryngology, National Hospital Organization Kyushu Medical Center

6. Department of Head and Neck Surgery, National Hospital Organization Shikoku Cancer Center

7. Division of Gastrointestinal Oncology, Shizuoka Cancer Center

8. Department of Otolaryngology-Head and Neck Surgery, Hokkaido University Graduate School of Medicine

9. Department of Medical Oncology, Kindai University Nara Hospital

10. Division of Radiation Oncology and Particle Therapy, National Cancer Center Hospital East

Publisher

Japan Society for Head and Neck Cancer

Subject

Oncology,Otorhinolaryngology

Link

https://www.jstage.jst.go.jp/article/jjhnc/45/3/45_330/_pdf

Reference21 articles.

1. 1） Bonner J.A., Harari P.M., Giralt J., et al: Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 354：567-578, 2006

2. 2） Vermorken J.B., Mesia R., Rivera F., et al: Platinum-based chemotherapy plus cetuximab in head and neck cancer. N Engl J Med 359：1116-1127, 2008

3. 3） Okano S., Yoshino T., Fujii M., et al: PhaseⅡ study of cetuximab plus concomitant boost radiotherapy in Japanese patients with locally advanced squamous cell carcinoma of the head and neck. Jpn J Clin Oncol 43：476-482, 2013

4. 4） Yoshino T., Hasegawa Y., Takahashi S., et al: Platinum-based chemotherapy plus cetuximab for the first-line treatment of Japanese patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: results of a phase Ⅱtrial. Jpn J Clin Oncol 43：524-531, 2013

5. 5） Report of Head and Neck Cancer Registry of Japan Clinical Statistics of Registered Patients, 2015. Japan Society for Head and Neck Cancer Cancer Registry Committee.